Literature DB >> 20039170

Co-existence of multidrug-resistant and -susceptible strains of Pseudomonas aeruginosa from a single clinical isolate.

Krishna Mahida1, Dong H Kwon.   

Abstract

Pseudomonas aeruginosa is a leading cause of hospital-acquired infections and difficult to treat due to acquired-resistance to multiple antibiotics. A pair of strains, M38100A and M38100B, previously identified from a single clinical isolate of P. aeruginosa was investigated to understand phenotypic and genotypic characteristics. Results revealed that the pair of strains was very similar for serum susceptibility, growth rate in a complex medium (Luria-Bertani), RAPD-genotype profiles, status of genes encoding type III secretion toxins, and no extra-chromosomal DNA. However, antibiotic susceptibility of the strain M38100B showed resistant to all tested-antibiotics while the strain M38100A showed susceptible to the same tested-antibiotics as similar levels of P. aeruginosa PAO1. The strain M38100B exhibited no growth in a minimal medium as a sole carbon and nitrogen source of glutamate while the strain M38100A grew well in the same minimal medium. These results suggest that multidrug resistance of the strain M38100B may be caused by multiple mutations on its genomic DNA and a precursor stage for a homogeneous multidrug resistant population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20039170     DOI: 10.1007/s00284-009-9570-0

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  32 in total

1.  Heteroresistance to vancomycin in Enterococcus faecium.

Authors:  M R Alam; S Donabedian; W Brown; J Gordon; J W Chow; M J Zervos; E Hershberger
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment.

Authors:  Robert E. W. Hancock; David P. Speert
Journal:  Drug Resist Updat       Date:  2000-08       Impact factor: 18.500

3.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 4.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

5.  Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.

Authors:  S Jalal; B Wretlind
Journal:  Microb Drug Resist       Date:  1998       Impact factor: 3.431

6.  Polyamines induce resistance to cationic peptide, aminoglycoside, and quinolone antibiotics in Pseudomonas aeruginosa PAO1.

Authors:  Dong H Kwon; Chung-Dar Lu
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

7.  Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation.

Authors:  B Henrichfreise; I Wiegand; W Pfister; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

8.  Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes.

Authors:  C Y Wang; J S Jerng; K Y Chen; K Y Cheng; L N Lee; C J Yu; P R Hsueh; P C Yang
Journal:  Clin Microbiol Infect       Date:  2006-01       Impact factor: 8.067

9.  Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.

Authors:  Yasmin Maor; Michal Hagin; Natasha Belausov; Nathan Keller; Debbi Ben-David; Galia Rahav
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

10.  Single-nucleotide-polymorphism mapping of the Pseudomonas aeruginosa type III secretion toxins for development of a diagnostic multiplex PCR system.

Authors:  Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  3 in total

1.  Antibiotic susceptibility and genotype patterns of Pseudomonas aeruginosa from mechanical ventilation-associated pneumonia in intensive care units.

Authors:  Hui Xiao; Xiong Ye; Qingzhong Liu; Li Li
Journal:  Biomed Rep       Date:  2013-04-16

2.  Treatment of infected lungs by ex vivo perfusion with high dose antibiotics and autotransplantation: A pilot study in pigs.

Authors:  Norman Zinne; Marcus Krueger; Doris Hoeltig; Burkhard Tuemmler; Erin C Boyle; Christian Biancosino; Klaus Hoeffler; Peter Braubach; Taufiek K Rajab; Anatol Ciubotaru; Judith Rohde; Karl-Heinz Waldmann; Axel Haverich
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

3.  Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients.

Authors:  Xuan Qin; Chuan Zhou; Danielle M Zerr; Amanda Adler; Amin Addetia; Shuhua Yuan; Alexander L Greninger
Journal:  mSphere       Date:  2018-03-14       Impact factor: 4.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.